These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33353779)

  • 41. REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.
    Vos NS; van der Schaaf RJ; Amoroso G; Herrman JP; Patterson MS; Slagboom T; Vink MA
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1213-21. PubMed ID: 26370515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of intravascular ultrasound findings in patients with a post PCI fractional flow reserve ≤0.85 on 2 year clinical outcome.
    van Zandvoort LJC; Masdjedi K; Neleman T; Tovar Forero MN; Wilschut J; den Dekker W; de Jaegere PPT; Diletti R; Zijlstra F; Van Mieghem NM; Daemen J
    Int J Cardiol; 2020 Oct; 317():33-36. PubMed ID: 32433997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Explanation of Postprocedural Fractional Flow Reserve Below 0.85.
    van Zandvoort LJC; Masdjedi K; Witberg K; Ligthart J; Tovar Forero MN; Diletti R; Lemmert ME; Wilschut J; de Jaegere PPT; Boersma E; Zijlstra F; Van Mieghem NM; Daemen J
    Circ Cardiovasc Interv; 2019 Feb; 12(2):e007030. PubMed ID: 30732469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI).
    Chen SL; Ye F; Zhang JJ; Xu T; Tian NL; Liu ZZ; Lin S; Shan SJ; Ge Z; You W; Liu YQ; Qian XS; Li F; Yang S; Kwan TW; Xu B; Stone GW
    JACC Cardiovasc Interv; 2015 Apr; 8(4):536-46. PubMed ID: 25819187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry.
    Van Belle E; Rioufol G; Pouillot C; Cuisset T; Bougrini K; Teiger E; Champagne S; Belle L; Barreau D; Hanssen M; Besnard C; Dauphin R; Dallongeville J; El Hahi Y; Sideris G; Bretelle C; Lhoest N; Barnay P; Leborgne L; Dupouy P;
    Circulation; 2014 Jan; 129(2):173-85. PubMed ID: 24255062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR-OCT co-registration study.
    Pyxaras SA; Adriaenssens T; Barbato E; Ughi GJ; Di Serafino L; De Vroey F; Toth G; Tu S; Reiber JHC; Bax JJ; Wijns W
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):495-502. PubMed ID: 29080150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of drug eluting stents on cardiovascular events in patients with intermediate lesions and borderline fractional flow reserve.
    Lavi S; Rihal CS; Yang EH; Fassa AA; Elesber A; Lennon RJ; Mathew V; David HR; Lerman A
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):525-31. PubMed ID: 17896397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve.
    Barbato E; Toth GG; Johnson NP; Pijls NH; Fearon WF; Tonino PA; Curzen N; Piroth Z; Rioufol G; Jüni P; De Bruyne B
    J Am Coll Cardiol; 2016 Nov; 68(21):2247-2255. PubMed ID: 27884241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and physiological outcomes of fractional flow reserve-guided percutaneous coronary intervention in patients with serial stenoses within one coronary artery.
    Kim HL; Koo BK; Nam CW; Doh JH; Kim JH; Yang HM; Park KW; Lee HY; Kang HJ; Cho YS; Youn TJ; Kim SH; Chae IH; Choi DJ; Kim HS; Oh BH; Park YB
    JACC Cardiovasc Interv; 2012 Oct; 5(10):1013-8. PubMed ID: 23078728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of target vessel on prognostic relevance of fractional flow reserve after coronary stenting.
    Hwang D; Lee JM; Lee HJ; Kim SH; Nam CW; Hahn JY; Shin ES; Matsuo A; Tanaka N; Matsuo H; Lee SY; Doh JH; Koo BK
    EuroIntervention; 2019 Aug; 15(5):457-464. PubMed ID: 30561367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic impact of fractional flow reserve measurements in patients with acute coronary syndromes: a subanalysis of the FLORIDA study.
    Gerhardt T; Stähli BE; Rudolph TK; Lutz M; Schatz AS; Zanders L; Schubert T; Stueve M; West NEJ; Boone E; Landmesser U; Leistner DM
    Heart Vessels; 2023 Aug; 38(8):1009-1018. PubMed ID: 37067577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of real-world patients with low fractional flow reserve immediately after drug-eluting stents implantation.
    Kimura Y; Tanaka N; Okura H; Yoshida K; Akabane M; Takayama T; Hirayama A; Tada T; Kimura T; Takano H; Mizuno K; Inami T; Yoshino H; Yamashina A
    Cardiovasc Interv Ther; 2016 Jan; 31(1):29-37. PubMed ID: 26135607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
    ; Lee JM; Choi KH; Koo BK; Dehbi HM; Doh JH; Nam CW; Shin ES; Cook CM; Al-Lamee R; Petraco R; Sen S; Malik IS; Nijjer SS; Mejía-Rentería H; Alegria-Barrero E; Alghamdi A; Altman J; Baptista SB; Bhindi R; Bojara W; Brugaletta S; Silva PC; Di Mario C; Erglis A; Gerber RT; Going O; Härle T; Hellig F; Indolfi C; Janssens L; Jeremias A; Kharbanda RK; Khashaba A; Kikuta Y; Krackhardt F; Laine M; Lehman SJ; Matsuo H; Meuwissen M; Niccoli G; Piek JJ; Ribichini F; Samady H; Sapontis J; Seto AH; Sezer M; Sharp ASP; Singh J; Takashima H; Talwar S; Tanaka N; Tang K; Van Belle E; van Royen N; Vinhas H; Vrints CJ; Walters D; Yokoi H; Samuels B; Buller C; Patel MR; Serruys P; Escaned J; Davies JE
    JAMA Cardiol; 2019 Sep; 4(9):857-864. PubMed ID: 31314045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Shin ES; Ann SH; Balbir Singh G; Lim KH; Kleber FX; Koo BK
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):193-200. PubMed ID: 26423017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baseline fractional flow reserve and stent diameter predict optimal post-stent fractional flow reserve and major adverse cardiac events after bare-metal stent deployment.
    Samady H; McDaniel M; Veledar E; De Bruyne B; Pijls NH; Fearon WF; Vaccarino V
    JACC Cardiovasc Interv; 2009 Apr; 2(4):357-63. PubMed ID: 19463450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic Implications of Fractional Flow Reserve and Coronary Flow Reserve After Drug-Eluting Stent Implantation.
    Ueno H; Hoshino M; Usui E; Sugiyama T; Kanaji Y; Hada M; Misawa T; Nagamine T; Hanyu Y; Nogami K; Sayama K; Matsuda K; Sakamoto T; Yonetsu T; Sasano T; Kakuta T
    Circ J; 2024 May; 88(6):853-859. PubMed ID: 37853607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Outcomes in Patients with Deferred Coronary Lesions according to Disease Severity Assessed by Fractional Flow Reserve.
    Won KB; Nam CW; Cho YK; Yoon HJ; Park HS; Kim H; Han S; Hur SH; Kim YN; Park SH; Han JK; Koo BK; Kim HS; Doh JH; Lee SY; Yang HM; Lim HS; Yoon MH; Tahk SJ; Kim KB
    J Korean Med Sci; 2016 Dec; 31(12):1929-1936. PubMed ID: 27822931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of Routine Fractional Flow Reserve for Clinical Management of Coronary Artery Disease in Patients With Diabetes.
    Van Belle E; Cosenza A; Baptista SB; Vincent F; Henderson J; Santos L; Ramos R; Pouillot C; Calé R; Cuisset T; Jorge E; Teiger E; Machado C; Belle L; Costa M; Barreau D; Oliveira E; Hanssen M; Costa J; Besnard C; Nunes L; Dallongeville J; Sideris G; Bretelle C; Fonseca N; Lhoest N; Guardado J; Silva B; Sousa MJ; Barnay P; Silva JC; Leborgne L; Rodrigues A; Porouchani S; Seca L; Fernandes R; Dupouy P; Raposo L;
    JAMA Cardiol; 2020 Mar; 5(3):272-281. PubMed ID: 31913433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower Level of Low Density Lipoprotein Cholesterol is Associated with a Higher Increase in the Fractional Flow Reserve in Patients with Fixed-dose Rosuvastatin.
    Hashikata T; Tojo T; Muramatsu Y; Sato T; Kakizaki R; Nemoto T; Fujiyoshi K; Namba S; Kitasato L; Hashimoto T; Kameda R; Shimohama T; Yamaoka-Tojo M; Ako J
    J Atheroscler Thromb; 2018 Mar; 25(3):233-243. PubMed ID: 28824048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.